DePuy Synthes נותנת מענה לביקוש הקליני להפחית את המקרים של זיהומים
שקשורים לשתלים באמצעות Expert Tibial Nail PROtect
המסמר התוך לשדי היחיד עם ציפוי אנטיביוטי נספג מחדש שנמצא בשוק כיום
פותח כדי לספק הגנה ממוקדת מפני התיישבות של חיידקים
DePuy Synthes, חלק ממשפחת החברות של Johnson & Johnson,הודיעה היום על הזמינות של Expert Tibial Nail PROtect, המסמר לעצם השוק היחיד עם ציפוי אנטיביוטי נספג מחדש שמיועד לספק הגנה נוספת מפני התיישבות של חיידקים לחולים שבסיכון גבוה לזיהום. זיהום בעקבות קיבוע שברים מוכר כבעיה קלינית שחשיבותה הולכת וגדלה, ותוצאותיה יכולות להיות טיפול ממושך, החלמה לקויה של השבר ובמקרים מסוימים, לדוגמה אנשים עם סוכרת, קטיעה של האיבר1–3.
DePuy Synthes Addresses Clinical Demand to Reduce the Incidence of Implant Related Infections with Expert Tibial Nail PROtect
The only intramedullary nail with a resorbable antibiotic coating on the market today.
Developed to deliver targeted protection against bacterial colonization.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced the availability of Expert Tibial Nail PROtect, the only tibial nail with a resorbable antibiotic coating designed to provide additional protection from bacterial colonization for patients who are at high risk of infection. Infection following fracture fixation is recognised as an increasingly important clinical problem, and can result in prolonged treatment, impaired fracture healing and in some cases, for example people with diabetes, may result in limb amputation1–3.
“Infection following fracture fixation is one of the most severe problems we face in daily practice, with potentially devastating consequences for the patient,” said Prof. Dr. med Michael Raschke*, Clinical Director, University of Muenster, Germany. “A biofilm can form on an implant within 12–18 hours post-surgery which may trigger an infection5.”
Adding locally administered antibiotics to general prophylactic antibiotics has been shown to reduce the infection rate for patients with severe fractures from 14.4% to 2.4%6. Expert Tibial Nail PROtect offers a treatment option developed to deliver targeted protection and prevent a bacterial biofilm forming on the implant thus decreasing the risk of infection.
The Expert Tibial Nail’s use in tibia fracture repair, demonstrates improved patient outcomes, which is why it was selected for application of the PROtect antibiotic coating7. The design of Expert Tibial Nail itself has been shown to reduce operating time, hospital stay, full weight bearing time and union time8.
DePuy Synthes Companies, part of the Johnson & Johnson Family of Companies, provides one of the most comprehensive portfolios of orthopaedic solutions in the world. DePuy Synthes Companies solutions, in specialties including joint reconstruction, trauma, neurological, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide.
DePuy Synthes, part of the Johnson & Johnson Family of Companies
2. Hannigan GD, Pulos N, Grice EA, Mehta S. Current Concepts and Ongoing Research in the Prevention and Treatment of Open Fracture Infections. Advances in wound care 2015;4:59-74.
4. McHugh SM, Collins CJ, Corrigan MA, Hill AD, Humphreys H. The role of topical antibiotics used as prophylaxis in surgical site infection prevention. The Journal of Antimicrobial Chemotherapy 2011;66:693-701.
6. Craig J, Fuchs T, Jenks M, et al. Systematic review and meta-analysis of the additional benefit of local prophylactic antibiotic therapy for infection rates in open tibia fractures treated with intramedullary nailing. International orthopaedics 2014;38:1025-30.
8. Li Y, Liu L, Tang X, Pei F, Wang G, Fang Y, Zhang H, Crook N (2012) Comparison of low, multidirectional locked nailing and plating in the treatment of distal tibial metaphyseal fractures. Int Orthop 36(7):1457-62.
10. Fuchs T, Stange R, Schmidmaier G, Raschke MJ. The use of gentamicin-coated nails in the tibia: preliminary results of a prospective study. Archives of orthopaedic and trauma surgery 2011;131:1419-25.
12. Metsemakers WJ, Reul M, Nijs S. The use of gentamicin-coated nails in complex open tibia fracture and revision cases: A retrospective analysis of a single centre case series and review of the literature. Injury 2015;46:2433-7.
13. DePuy Synthes Trauma adoSG. Resource Utilization and Costs of Patients with Tibia Fractures and Related Infections. Data on File. 2016.
DePuy Synthes
Jennifer Holden
Sr. Manager, Communications
[email protected]
View this news release online at:
http://www.businesswire.com/news/home/20161031005861/en
*** הידיעה מופצת בעולם על ידי חברת התקשורת הבינלאומית Business Wire
תגיות של המאמר:
|
